Thomas E Havel, MD
Psychiatry · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 6 carriers
- Office
- 1
Offices
1 location · Altos Health Partners · 4 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
22 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Havel’s office at (650) 988-7626 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G32044 · Current
Licensed to practise in California · since 1976 · expires 2027-10-31 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$38,230
Medicare paid this office $38,230 for 60 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Therapy using electrical currents | 16 | $10,972 | $88 |
| Return visit (30+ min) | 38 | $9,948 | $79 |
| Psychotherapy with evaluation and management visit, 30 minutes | 22 | $4,229 | $54 |
| Return visit (30+ min) | 11 | $4,146 | $115 |
Who their Medicare patients are
60 Original Medicare patients in 2024. Average age 76 · Women 68% · Health risk score 1.32. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 68% · Chronic kidney disease 28% · Coronary heart disease 25% · Diabetes 22% · Atrial fibrillation 18%.
The office billed $173,401, Medicare allowed $48,750 and paid $38,230; for 453 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 60 | 453 | 76 | 1.32 | $173,401 | $38,230 |
| 2023 | 47 | 226 | 75 | 1.14 | $81,065 | $21,564 |
| 2022 | 49 | 254 | 71 | 0.95 | $90,380 | $24,097 |
| 2021 | 51 | 329 | 70 | 1.00 | $121,825 | $32,124 |
| 2020 | 48 | 293 | 69 | 1.37 | $116,975 | $26,424 |
| 2019 | 78 | 430 | 65 | 1.20 | $168,855 | $38,819 |
| 2018 | 68 | 364 | 68 | 1.26 | $111,250 | $29,936 |
| 2017 | 49 | 359 | 69 | 1.11 | $121,809 | $30,952 |
| 2016 | 54 | 481 | 65 | 1.28 | $168,511 | $42,157 |
| 2015 | 54 | 404 | 67 | 1.17 | $127,770 | $36,687 |
| 2014 | 68 | 521 | 64 | 1.13 | $167,830 | $48,194 |
| 2013 | 60 | 492 | 60 | 1.48 | $134,700 | $34,747 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 32 | $8,834 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,940 | $97 |
| New patient visit (60+ min) | 11 | $1,730 | $157 |
2022: 1 service
| Return visit (30+ min) | 28 | $8,796 | $84 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $10,948 | $90 |
| Return visit (30+ min) | 23 | $7,860 | $86 |
| Return visit (30+ min) | 12 | $5,752 | $120 |
| New patient visit (45+ min) | 12 | $1,347 | $112 |
2020: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $12,199 | $89 |
| Return visit (30+ min) | 18 | $3,242 | $65 |
| New patient visit (45+ min) | 14 | $1,461 | $104 |
2019: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $13,158 | $88 |
| Therapy using electrical currents | 12 | $6,390 | $93 |
| Return visit (30+ min) | 14 | $4,663 | $91 |
| Return visit (30+ min) | 29 | $4,367 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,296 | $172 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,578 | $93 |
| New patient visit (45+ min) | 13 | $1,419 | $109 |
| Family psychotherapy with patient, 50 minutes | 11 | $1,045 | $87 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $8,118 | $84 |
| Return visit (30+ min) | 17 | $6,407 | $89 |
| Return visit (30+ min) | 24 | $3,991 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,401 | $160 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $13,438 | $86 |
| Therapy using electrical currents | 16 | $7,531 | $90 |
| Return visit (30+ min) | 13 | $4,377 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,838 | $167 |
| Hospital discharge day management, more than 30 minutes | 11 | $995 | $90 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $21,586 | $85 |
| Therapy using electrical currents | 22 | $11,009 | $90 |
| Return visit (30+ min) | 12 | $4,643 | $91 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,361 | $91 |
2015: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $16,479 | $90 |
| Therapy using electrical currents | 17 | $8,200 | $94 |
| Return visit (30+ min) | 15 | $5,080 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,294 | $176 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,715 | $95 |
2014: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $17,283 | $92 |
| Therapy using electrical currents | 17 | $14,229 | $97 |
| Return visit (30+ min) | 18 | $4,623 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,113 | $179 |
| Short return visit (20+ min) | 11 | $2,111 | $68 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,834 | $97 |
| Short return visit (20+ min) | 12 | $1,410 | $43 |
| Return visit (30+ min) | 11 | $824 | $69 |
2013: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $10,439 | $88 |
| Therapy using electrical currents | 15 | $8,425 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $4,172 | $63 |
| Short return visit (20+ min) | 14 | $1,988 | $48 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,899 | $95 |
| Short return visit (20+ min) | 14 | $831 | $33 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $439 | $26 |
Drugs they prescribed that Part D paid
$10,479
Pharmacies billed $10,479 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
407 generic and 11 brand-name prescriptions · $10,479 in drug cost · 66 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dextroamphetamine-Amphet Er | 18 | $858 | $48 |
| Divalproex Sodium Er | 13 | $849 | $65 |
| Mirtazapine | 26 | $470 | $18 |
| Quetiapine | 37 | $423 | $11 |
| Olanzapine | 11 | $412 | $37 |
See all 15 drugs
| Dextroamphetamine-Amphet Er | 18 | $858 | $48 |
| Divalproex Sodium Er | 13 | $849 | $65 |
| Mirtazapine | 26 | $470 | $18 |
| Quetiapine | 37 | $423 | $11 |
| Olanzapine | 11 | $412 | $37 |
| Bupropion Xl | 17 | $358 | $21 |
| Clonazepam | 40 | $355 | $9 |
| Gabapentin | 29 | $342 | $12 |
| Duloxetine | 21 | $301 | $14 |
| Trazodone | 43 | $292 | $7 |
| Aripiprazole | 17 | $217 | $13 |
| Sertraline | 19 | $206 | $11 |
| Escitalopram | 18 | $132 | $7 |
| Lorazepam | 13 | $100 | $8 |
| Buspirone | 17 | $89 | $5 |
Year by year
| 2024 | 418 | 43 | None | 3% | $10,479 |
| 2023 | 407 | 41 | None | 0% | $8,957 |
| 2022 | 594 | 45 | 0% (0) | None | $12,194 |
| 2021 | 374 | 47 | 0% (0) | 4% | $24,255 |
| 2020 | 319 | 40 | None | 5% | $29,294 |
| 2019 | 433 | 52 | None | 8% | $34,964 |
| 2018 | 453 | 52 | None | 5% | $31,902 |
| 2017 | 338 | 33 | None | None | $12,524 |
| 2016 | 376 | 38 | None | 7% | $34,582 |
| 2015 | 407 | 39 | None | 9% | $49,070 |
| 2014 | 501 | 47 | 4% (20) | 10% | $43,697 |
| 2013 | 452 | 40 | 4% (18) | 17% | $46,210 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Divalproex Sodium Er | 14 | $1,224 | $87 |
| Quetiapine | 25 | $598 | $24 |
| Mirtazapine | 25 | $592 | $24 |
| Gabapentin | 33 | $552 | $17 |
| Trazodone | 42 | $493 | $12 |
| Clonazepam | 53 | $459 | $9 |
| Duloxetine | 11 | $402 | $37 |
| Lithium Carbonate Er | 11 | $311 | $28 |
| Bupropion Xl | 13 | $291 | $22 |
| Sertraline | 27 | $242 | $9 |
| Escitalopram | 17 | $239 | $14 |
| Buspirone | 23 | $187 | $8 |
| Venlafaxine Hcl Er | 12 | $171 | $14 |
| Lorazepam | 18 | $141 | $8 |
2022: 17 drugs
| Quetiapine | 37 | $2,202 | $60 |
| Dextroamphetamine Sulfate | 14 | $1,173 | $84 |
| Gabapentin | 61 | $722 | $12 |
| Aripiprazole | 19 | $678 | $36 |
| Duloxetine | 26 | $669 | $26 |
| Trazodone | 76 | $652 | $9 |
| Bupropion Xl | 23 | $494 | $21 |
| Clonazepam | 70 | $480 | $7 |
| Escitalopram | 15 | $332 | $22 |
| Mirtazapine | 24 | $284 | $12 |
| Buspirone | 31 | $241 | $8 |
| Lithium Carbonate Er | 15 | $234 | $16 |
| Sertraline | 35 | $222 | $6 |
| Fluoxetine | 14 | $95 | $7 |
| Lorazepam | 17 | $92 | $5 |
| Risperidone | 11 | $70 | $6 |
| Alprazolam | 16 | $66 | $4 |
2021: 10 drugs
| Gabapentin | 48 | $800 | $17 |
| Aripiprazole | 21 | $625 | $30 |
| Trazodone | 46 | $440 | $10 |
| Bupropion Xl | 23 | $431 | $19 |
| Duloxetine | 22 | $377 | $17 |
| Clonazepam | 52 | $310 | $6 |
| Escitalopram | 12 | $287 | $24 |
| Buspirone | 11 | $141 | $13 |
| Mirtazapine | 14 | $110 | $8 |
| Fluoxetine | 11 | $96 | $9 |
2020: 10 drugs
| Rexulti | 11 | $13,570 | $1,234 |
| Aripiprazole | 11 | $864 | $79 |
| Gabapentin | 30 | $659 | $22 |
| Escitalopram | 22 | $644 | $29 |
| Clonazepam | 43 | $480 | $11 |
| Memantine | 15 | $470 | $31 |
| Olanzapine | 14 | $460 | $33 |
| Trazodone | 23 | $279 | $12 |
| Quetiapine | 15 | $249 | $17 |
| Buspirone | 11 | $99 | $9 |
2019: 15 drugs
| Vraylar | 13 | $9,993 | $769 |
| Aripiprazole | 18 | $1,511 | $84 |
| Quetiapine | 31 | $759 | $24 |
| Bupropion Xl | 31 | $602 | $19 |
| Gabapentin | 43 | $559 | $13 |
| Clonazepam | 37 | $425 | $11 |
| Risperidone | 12 | $385 | $32 |
| Mirtazapine | 13 | $343 | $26 |
| Escitalopram | 15 | $321 | $21 |
| Olanzapine | 15 | $314 | $21 |
| Sertraline | 23 | $269 | $12 |
| Trazodone | 21 | $254 | $12 |
| Hydroxyzine | 14 | $219 | $16 |
| Fluoxetine | 15 | $187 | $12 |
| Lorazepam | 12 | $107 | $9 |
2018: 15 drugs
| Vraylar | 12 | $14,810 | $1,234 |
| Aripiprazole | 21 | $2,413 | $115 |
| Risperidone | 25 | $1,007 | $40 |
| Bupropion Xl | 13 | $618 | $48 |
| Olanzapine | 40 | $559 | $14 |
| Quetiapine | 32 | $526 | $16 |
| Mirtazapine | 18 | $521 | $29 |
| Gabapentin | 34 | $433 | $13 |
| Memantine | 19 | $429 | $23 |
| Fluoxetine | 21 | $307 | $15 |
| Escitalopram | 13 | $299 | $23 |
| Buspirone | 22 | $281 | $13 |
| Clonazepam | 26 | $179 | $7 |
| Sertraline | 13 | $165 | $13 |
| Trazodone | 25 | $158 | $6 |
2017: 11 drugs
| Aripiprazole | 11 | $1,059 | $96 |
| Fluoxetine | 23 | $623 | $27 |
| Quetiapine | 23 | $360 | $16 |
| Olanzapine | 26 | $315 | $12 |
| Gabapentin | 40 | $289 | $7 |
| Sertraline | 14 | $240 | $17 |
| Escitalopram | 13 | $227 | $17 |
| Risperidone | 13 | $220 | $17 |
| Clonazepam | 35 | $216 | $6 |
| Amitriptyline | 12 | $124 | $10 |
| Lamotrigine | 12 | $73 | $6 |
2016: 12 drugs
| Aripiprazole | 17 | $4,402 | $259 |
| Olanzapine | 40 | $695 | $17 |
| Fluoxetine | 16 | $614 | $38 |
| Quetiapine | 24 | $457 | $19 |
| Venlafaxine Hcl Er | 15 | $393 | $26 |
| Lorazepam | 21 | $284 | $14 |
| Clonazepam | 31 | $201 | $6 |
| Levothyroxine | 13 | $175 | $13 |
| Trazodone | 27 | $135 | $5 |
| Mirtazapine | 13 | $125 | $10 |
| Gabapentin | 13 | $102 | $8 |
| Simvastatin | 14 | $23 | $2 |
2015: 15 drugs
| Clozaril | 14 | $23,058 | $1,647 |
| Duloxetine | 15 | $1,579 | $105 |
| Risperidone | 15 | $1,514 | $101 |
| Olanzapine | 41 | $1,160 | $28 |
| Ziprasidone | 11 | $900 | $82 |
| Quetiapine | 13 | $395 | $30 |
| Zolpidem | 20 | $338 | $17 |
| Venlafaxine Hcl Er | 13 | $267 | $21 |
| Lorazepam | 27 | $222 | $8 |
| Gabapentin | 16 | $201 | $13 |
| Levothyroxine | 14 | $199 | $14 |
| Clonazepam | 39 | $187 | $5 |
| Fluoxetine | 11 | $158 | $14 |
| Sertraline | 13 | $140 | $11 |
| Mirtazapine | 13 | $129 | $10 |
2014: 15 drugs
| Clozaril | 12 | $18,288 | $1,524 |
| Duloxetine | 14 | $2,008 | $143 |
| Quetiapine | 30 | $1,873 | $62 |
| Bupropion Xl | 20 | $1,081 | $54 |
| Olanzapine | 36 | $1,005 | $28 |
| Risperidone | 20 | $457 | $23 |
| Zolpidem | 50 | $357 | $7 |
| Clonazepam | 43 | $323 | $8 |
| Venlafaxine Hcl Er | 12 | $302 | $25 |
| Sertraline | 19 | $291 | $15 |
| Lorazepam | 27 | $210 | $8 |
| Mirtazapine | 14 | $116 | $8 |
| Nortriptyline | 13 | $85 | $7 |
| Hydrocodone-Acetaminophen | 12 | $83 | $7 |
| Simvastatin | 13 | $73 | $6 |
2013: 14 drugs
| Clozaril | 14 | $17,951 | $1,282 |
| Cymbalta | 20 | $4,486 | $224 |
| Quetiapine | 26 | $3,109 | $120 |
| Zolpidem Tartrate Er | 12 | $1,206 | $100 |
| Risperidone | 13 | $1,137 | $87 |
| Olanzapine | 37 | $1,062 | $29 |
| Clonazepam | 41 | $371 | $9 |
| Zolpidem | 40 | $301 | $8 |
| Venlafaxine Hcl Er | 18 | $296 | $16 |
| Gabapentin | 15 | $267 | $18 |
| Lorazepam | 21 | $150 | $7 |
| Mirtazapine | 12 | $111 | $9 |
| Lamotrigine | 13 | $94 | $7 |
| Tramadol | 13 | $92 | $7 |
Money from drug and device companies
$32 in 2023
| 2023 | 1 | 1 | None | $32 |
| 2019 | 1 | 1 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vanda Pharmaceuticals | Hetlioz | $32 | 1 payment
|
See the published payment
| Vanda Pharmaceuticals | Meals · 2023-03-28 | Hetlioz | $32 |
See earlier years (2019)
2019: $119
| Neurocrine Biosciences | Ingrezza | $119 | 1 payment
|
Professional record
- NPI
- 1871625194
- Licence
- CA G32044California G32044: Current · expires 2027-10-31
- Trained
- Georgetown University School of Medicine, 1975
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G320440
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- Po Box 1347, Los Altos, CA, 94023
- NPI first listed
- 2007-03-12
- NPI last updated
- 2025-08-08
- NPI record certified
- 2025-08-08
This is when the NPI record was last certified, not a medical board exam.